| 15888438
|
Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. |
J Biol Chem |
2005 |
Grassme H;Riehle A;Wilker B;Gulbins E |
View
More |
| 27022874
|
Development of intranasal nanovehicles of itraconazole and their immunological activities for the therapy of rhinovirus infection. |
Colloids Surf B Biointerfaces |
2016 |
Lee JJ;Shim A;Jeong JY;Lee SY;Ko HJ;Cho HJ |
View
More |
| 28088167
|
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. |
BMC Infect Dis |
2017 |
Mukherjee PK;Esper F;Buchheit K;Arters K;Adkins I;Ghannoum MA;Salata RA |
View
More |
| 32419645
|
Coldzyme(R) Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions. |
Eur J Sport Sci |
2021 |
Davison G;Perkins E;Jones AW;Swart GM;Jenkins AR;Robinson H;Dargan K |
View
More |
| 32975843
|
Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme(R) a medical device mouth spray against the common cold. |
J Med Virol |
2021 |
Gudmundsdottir A;Scheving R;Lindberg F;Stefansson B |
View
More |
| 35789217
|
Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial. |
PLoS One |
2022 |
Lindberg F;Nelson I;Ranstam J;Riker DK |
View
More |
| 36652464
|
Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study. |
PLoS One |
2023 |
Lindberg BF;Nelson I;Ranstam J;Riker DK |
View
More |
| 4327717
|
On the structure of rhinovirus 1A. |
Virology |
1971 |
Medappa KC;McLean C;Rueckert RR |
View
More |
